Antithyroid drugs used in the treatment of hyperthyroidism during breast feeding. An update and new perspectives

Hormones

Volumn 8, Issue 4, 2009, Pages 254-257

  Karras, Spyros ^a   Tzotzas, Themistoklis ^a   Krassas, Gerasimos E ^a  

^a PANAGIA GENERAL HOSPITAL   (Greece)

Author keywords

Antithyroid drugs; Breast feeding; Graves' disease; Lactating thyrotoxic mothers; Methimazole; Propilthiuracil

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTITHYROID AGENT; PROPYLTHIOURACIL; THIAMAZOLE;

AGRANULOCYTOSIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; BREAST FEEDING; COHORT ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SAFETY; FEVER; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; LACTATION; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; NOTE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREGNANCY; RASH; THYROTOXICOSIS; TREATMENT DURATION; URTICARIA; VASCULITIS;

EID: 74849106088     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1248     Document Type: Note

References (31)

1. Mandel SJ, Cooper DS, 2001 The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 86: 2354-2359.
2. Abalovich M, Amino N, Barbour LA, et al, 2007 Management of thyroid dysfunction during Pregnancy and Postpartum. J Clin Endocrinol Metab 92: Suppl 8: S1-S47.
3. Cooper DS, 2003 Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab 88: 3474-3481.
4. Cooper DS, 2005 Antithyroid drugs. N Engl J Med 352: 905-917.
5. He CT, Hsieh AT, Pei D, et al, 2004 Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. Clin Endocrinol (Oxf) 60: 676-681.
6. Tsatsoulis A, Vlachoyiannopoulos PG, Dalekos GN, Johnson EO, Moutsopoulos HM, 1995 Increased serum interleukin-1 beta during treatment of hyperthyroidism with antithyroid drugs. Eur J Clin Invest 25: 654-658.
7. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Chrousos GP, Koutras DA, 2000 Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease. Thyroid 10: 527-532.
8. Harper L, Chin L, Daykin J, et al, 2004 Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease. Clin Endocrinol (Oxf) 60: 671-675.
9. Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH, 2008 Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology (Oxf) 47: 1515-1520.
10. Sato H, Hattori M, Fujieda M, et al, 2000 High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J Clin Endocrinol Metab 85: 4270-4273.
11. Azizi F, 1996 Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants. J Pediatr 128: 855-858.
12. Azizi F, Hedayati M, 2002 Thyroid function in breast-fed infants whose mothers take high doses of methimazole. J Endocrinol Invest 25: 493-496.
13. Azizi F, 2003 Thyroid function in breast-fed infants is not affected by methimazole-induced maternal hypothyroidism: results of a retrospective study. J Endocrinol Invest 26: 301-304.
14. Ordookhani A, Pearce EN, Hedayati M, et al, 2007 Assessment of thyroid function and urinary and breast milk iodine concentrations in healthy newborns and their mothers in Tehran. Clin Endocrinol (Oxf) 67: 175-179.
15. Azizi F, Khoshniat M, Bahrainian M, Hedayati M, 2000 Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 85: 3233-3238.
16. Azizi F, Bahrainian M, Khamseh ME, Khoshniat M, 2003 Intellectual development and thyroid function in children who were breast-fed by thyrotoxic mothers taking methimazole. Pediatr Endocrinol Metab 16: 1239-1243.
17. Moore FD, 1946 Toxic manifestations of thiouracil therapy. JAMA 130: 315-319.
18. Arab DM, Malatjalian DA, Rittmaster RS, 1995 Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole. J Clin Endocrinol Metab 80: 1083-1085.
19. Williams KV, Nayak S, Becker D, Reyes J, Burmeister LA, 1997 Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? J Clin Endocrinol Metab 82: 1727-1733.
20. Ruiz JK, Rossi GV, Vallejos HA, Brenet RW, Lopez IB, Escribano AA, 2003 Fulminant hepatic failure associated with propylthiouracil. Ann Pharmacother 37: 224-228.
21. Liaw YF, Huang MJ, Fan KD, Li KL, Wu SS, Chen TJ, 1993 Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intern Med 118: 424-428.
22. Kim HJ, Kim BH, Han YS, et al, 2001 The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study. Am J Gastroenterol 96: 165-169.
23. Lian XL, Bai Y, Dai WX, Jin ZM, Zeng ZP, Guo ZS, 2004 The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism. Zhonghua Nei Ke Za Zhi 43: 442-446.
24. Van Dijke CP, Heydendael RJ, De Kleine MJ, 1987 Methimazole, carbimazole, and congenital skin defects. Ann Intern Med 106: 60-61.
25. Barbero P, Valdez R, Rodríguez H, et al, 2008 Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A 146A: 2390-2395.
26. Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2008 Hepatic toxicity following treatment for pediatric Graves' disease. Minutes of October 28 2008 meeting.
27. U.S. Food and Drug Administration, 2009 Propylthiouracyl (PTU)-related liver toxicity. April 18 2009 workshop.
28. Bahn RS, Burch HS, Cooper DS, et al, 2009 The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 19: 673-674.
29. Kampmann JP, Johansen K, Hansen JM, Helweg J, 1980 Propylthiouracil in human milk. Revision of a dogma. Lancet 1: 736-737.
30. Low LC, Lang J, Alexander WD, 1979 Excretion of carbimazole and propylthiouracil in breast milk. Lancet 2: 1011.
31. American Academy of Pediatrics Committee on Drugs, 2001 Transfer of drugs and other chemicals into human milk. Pediatrics 108: 776-789.